Requirement of NEMO/IKKγ for effective expansion of KRAS-induced precancerous lesions in the pancreas

Oncogene

Volumn 32, Issue 21, 2013, Pages 2690-2695

  Maier, H J ^a   Wagner, M ^a   Schips, T G ^a,c   Salem, H H ^a,b   Baumann, B ^a   Wirth, T ^a  

^a UNIVERSITY OF ULM   (Germany)

^b CAIRO UNIVERSITY   (Egypt)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

animal model; KRAS; NEMO IKKg; pancreatic carcinoma; Pancreatic intraepithelial neoplasia

Indexed keywords

I KAPPA B KINASE GAMMA; INTERLEUKIN 6; K RAS PROTEIN; STAT3 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; INFLAMMATION; MOUSE; NONHUMAN; PANCREAS CANCER; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PROTEIN FUNCTION;

ANIMALS; I-KAPPA B KINASE; INTERLEUKIN-6; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MAP KINASE SIGNALING SYSTEM; MICE; NEOPLASMS, EXPERIMENTAL; PANCREAS; PANCREATIC NEOPLASMS; PRECANCEROUS CONDITIONS; PROTO-ONCOGENE PROTEINS P21(RAS); RECEPTORS, NOTCH; STAT3 TRANSCRIPTION FACTOR;

ANIMALIA; MUS;

EID: 84878220272     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.272     Document Type: Article

References (34)

1. Schneider G, Siveke JT, Eckel F, Schmid RM. Pancreatic cancer: basic and clinical aspects. Gastroenterology 2005; 128: 1606-1625.
2. Hidalgo M. Pancreatic cancer. N Engl J Med 2010; 362: 1605-1617.
3. Hruban RH, Maitra A, Goggins M. Update on pancreatic intraepithelial neoplasia. Int J Clin Exp Pathol 2008; 1: 306-316.
4. Lohr M, Kloppel G, Maisonneuve P, Lowenfels AB, Luttges J. Frequency of K-ras mutations in pancreatic intraductal neoplasias associated with pancreatic ductal adenocarcinoma and chronic pancreatitis: a meta-analysis. Neoplasia 2005; 7: 17-23.
5. Hruban RH, Maitra A, Schulick R, Laheru D, Herman J, Kern SE et al. Emerging molecular biology of pancreatic cancer. Gastrointest Cancer Res 2008; 2: S10-S15.
6. Hezel AF, Kimmelman AC, Stanger BZ, Bardeesy N, Depinho RA. Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev 2006; 20: 1218-1249.
7. Ben-Neriah Y, Karin M. Inflammation meets cancer, with NF-kappaB as the matchmaker. Nat Immunol 2011; 12: 715-723.
8. Wang W, Abbruzzese JL, Evans DB, Larry L, Cleary KR, Chiao PJ. The nuclear factorkappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells. Clin Cancer Res 1999; 5: 119-127.
9. Oeckinghaus A, Ghosh S. The NF-kappaB family of transcription factors and its regulation. Cold Spring Harb Perspect Biol 2009; 1: a000034.
10. Baumgart S, Ellenrieder V, Fernandez-Zapico ME. Oncogenic transcription factors: cornerstones of inflammation-linked pancreatic carcinogenesis. Gut (e-pub ahead of print13 October 2011, doi:10.1136/gutjnl-2011-301008).
11. Liptay S, Weber CK, Ludwig L, Wagner M, Adler G, Schmid RM. Mitogenic and antiapoptotic role of constitutive NF-kappaB/Rel activity in pancreatic cancer. Int J Cancer 2003; 105: 735-746.
12. Maier HJ, Schmidt-Strassburger U, Huber MA, Wiedemann EM, Beug H, Wirth T. NF-kappaB promotes epithelial-mesenchymal transition, migration and invasion of pancreatic carcinoma cells. Cancer Lett 2010; 295: 214-228.
13. Hingorani SR, Petricoin EF, Maitra A, Rajapakse V, King C, Jacobetz MA et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 2003; 4: 437-450.
14. Herrera PL. Adult insulin-and glucagon-producing cells differentiate from two independent cell lineages. Development 2000; 127: 2317-2322.
15. Schmidt-Supprian M, Bloch W, Courtois G, Addicks K, Israel A, Rajewsky K et al. NEMO/IKK gamma-deficient mice model incontinentia pigmenti. Mol Cell 2000; 5: 981-992.
16. Hruban RH, Adsay NV, Albores-Saavedra J, Compton C, Garrett ES, Goodman SN et al. Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol 2001; 25: 579-586.
17. Fukuda A, Wang SC, Morris JPt, Folias AE, Liou A, Kim GE et al. Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression. Cancer Cell 2011; 19: 441-455.
18. Lesina M, Kurkowski MU, Ludes K, Rose-John S, Treiber M, Kloppel G et al. Stat3/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer. Cancer Cell 2011; 19: 456-469.
19. Corcoran RB, Contino G, Deshpande V, Tzatsos A, Conrad C, Benes CH et al. STAT3 plays a critical role in KRAS-induced pancreatic tumorigenesis. Cancer Res 2011; 71: 5020-5029.
20. Guerra C, Schuhmacher AJ, Canamero M, Grippo PJ, Verdaguer L, Perez-Gallego L et al. Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice. Cancer Cell 2007; 11: 291-302.
21. Guerra C, Collado M, Navas C, Schuhmacher AJ, Hernandez-Porras I, Canamero M et al. Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence. Cancer Cell 2011; 19: 728-739.
22. Funahashi H, Satake M, Dawson D, Huynh NA, Reber HA, Hines OJ et al. Delayed progression of pancreatic intraepithelial neoplasia in a conditional Kras(G12D) mouse model by a selective cyclooxygenase-2 inhibitor. Cancer Res 2007; 67: 7068-7071.
23. Fendrich V, Chen NM, Neef M, Waldmann J, Buchholz M, Feldmann G et al. The angiotensin-I-converting enzyme inhibitor enalapril and aspirin delay progression of pancreatic intraepithelial neoplasia and cancer formation in a genetically engineered mouse model of pancreatic cancer. Gut 2010; 59: 630-637.
24. Greer JB, Whitcomb DC. Inflammation and pancreatic cancer: an evidence-based review. Curr Opin Pharmacol 2009; 9: 411-418.
25. Ji H, Houghton AM, Mariani TJ, Perera S, Kim CB, Padera R et al. K-ras activation generates an inflammatory response in lung tumors. Oncogene 2006; 25: 2105-2112.
26. Aleksic T, Baumann B, Wagner M, Adler G, Wirth T, Weber CK. Cellular immune reaction in the pancreas is induced by constitutively active IkappaB kinase-2. Gut 2007; 56: 227-236.
27. Baumann B, Wagner M, Aleksic T, von Wichert G, Weber CK, Adler G et al. Constitutive IKK2 activation in acinar cells is sufficient to induce pancreatitis in vivo. J Clin Invest 2007; 117: 1502-1513.
28. Ying H, Elpek KG, Vinjamoori A, Zimmerman SM, Chu GC, Yan H et al. Pten is a major tumor suppressor in pancreatic ductal adenocarcinoma and regulates an NF-kappaB-cytokine network. Cancer Discov 2011; 1: 158-169.
29. Ling J, Kang Y, Zhao R, Xia Q, Lee DF, Chang Z et al. KrasG12D-induced IKK2/beta/NF-kappaB activation by IL-1alpha and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma. Cancer Cell 2012; 21: 105-120.
30. Daniluk J, Liu Y, Deng D, Chu J, Huang H, Gaiser S et al. An NF-kappaB pathway-mediated positive feedback loop amplifies Ras activity to pathological levels in mice. J Clin Invest 2012; 122: 1519-1528.
31. Maniati E, Bossard M, Cook N, Candido JB, Emami-Shahri N, Nedospasov SA et al. Crosstalk between the canonical NF-kappaB and Notch signaling pathways inhibits Ppargamma expression and promotes pancreatic cancer progression in mice. J Clin Invest 2011; 121: 4685-4699.
32. Nenci A, Becker C, Wullaert A, Gareus R, van Loo G, Danese S et al. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature 2007; 446: 557-561.
33. Luedde T, Beraza N, Kotsikoris V, van Loo G, Nenci A, De Vos R et al. Deletion of NEMO/IKKgamma in liver parenchymal cells causes steatohepatitis and hepato-cellular carcinoma. Cancer Cell 2007; 11: 119-132.
34. Vlantis K, Wullaert A, Sasaki Y, Schmidt-Supprian M, Rajewsky K, Roskams T et al. Constitutive IKK2 activation in intestinal epithelial cells induces intestinal tumors in mice. J Clin Invest 2011; 121: 2781-2793.